Gold Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.50 Cr
- Revenue Growth 18941.59%
- Profit Growth -756.33%
- Ebitda -1031.99%
- Net Worth -384.92%
- Total Assets 46.12%
About Gold Pharma
Gold Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 2019 (Six years and one month 2 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Corporate was formerly known as Ritvis Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹31.50 Cr.
Kanakamedala Suumaanth and Govind Chinta serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304AP2019PTC110225
-
Company No.
110225
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jan 2019
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Gold Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanakamedala Suumaanth
|
Director | 11-Jan-2019 | Current |
|
Govind Chinta
|
Director | 17-Aug-2022 | Current |
Financial Performance of Gold Pharma.
Gold Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18941.59% increase. The company also saw a substantial fall in profitability, with a 756.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 384.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gold Pharma?
In 2023, Gold Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cvr Life Sciences Private LimitedGovind Chinta is a mutual person
-
Navayuga Engineering Company LimitedGovind Chinta is a mutual person
-
Navayuga Intercontinental LlpGovind Chinta is a mutual person
-
Oju Subansiri Hydro Power Corporation Private Limited
Govind Chinta is a mutual person
-
Chinta Engicon Private Limited
Govind Chinta is a mutual person
-
Trivolve Tech Private Limited
Govind Chinta is a mutual person
Charges (Loans)
₹31.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 18.00 Cr
- Others : 13.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2022 | Axis Bank Limited | ₹18.00 Cr | Open |
| 20 Jan 2020 | Others | ₹13.50 Cr | Open |
How Many Employees Work at Gold Pharma?
Gold Pharma has a workforce of 33 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gold Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gold Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
